CBI/EBD Group’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs. KEYNOTES FOR 2020!...
Please join us for BioNJ’s Sixth Annual Inspiring Women in STEM Conference taking place virtually on December 3 and 4, 2020 from 9:00 a.m.-12:15 p.m. The perfect opportunity to learn from the experiences of successful women who...
The premier event in malignant and non-malignant hematology will be all-virtual Attend the world’s most comprehensive hematology event of the year for an invaluable educational experience and the opportunity to...
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point...
The International Conference on Microbiome Engineering (ICME 2020) will bring together leaders and experts from cutting edge fields of microbiome engineering to discuss progress and needs to develop research, technology,...
Speakers: Mark Merchant (Genentech), Maryland Franklin (Covance Preclinical Oncology), Karen Rex (Amgen), Willem Overwijk (Nektar Therapeutics), Shelley Ackerman (Bolt Biotherapeutics) Organizers: Gregory Wagner and Betty Chang Date: 2020-12-08 Time: 8:45-13:00 Pacific Time Registration fee: (USD):...
As the tools and technologies that are available to study the skin microbiome become cheaper and more accessible, the fundamental mechanisms that link the skin microbiome with skin health are...
Extractable compounds with unknown identities are a common problem when conducting a chemical characterization study in support of medical device biocompatibility. With increasing instrument sensitivity, regulatory scrutiny, and the widespread...
Day 1: December 08, 2020 - In Vivo Models and Case Studies with Targeted Therapeutics Symposium Overview and Relevance to Contemporary Issues in Development of Therapeutic Agents for Oncology (Mark...
Massachusetts has long been the epicenter of biopharma research and development. Years of investment and collaboration between industry, education, and government has provided biopharma manufacturers a rich and deep talent...
Case Study: The project was started with the aim to identify lead series and lead compounds for the inhibition of NNMT to treat metabolic disorders. The project team faced numerous...
Research shows that an effective investor relations program can account for a 30% variance in a company’s valuation. Investor communications is a vital function at any publicly traded company, and...
